---
title: "Butterfly Network's chip licensing drove 71% U.S. growth; CEO says it will dwarf the probe business"
description: "The chip story is already revenue: third-quarter US growth of 71 percent came primarily from Embedded, Butterfly's chip-licensing line, including the Midjourney co-development. That counterparty has no outside investors and three studios suing it, and insider sale filings landed the same fortnight."
publisher: "The Inference"
section: "Chips"
published: 2026-11-17T16:08:51.396Z
modified: 2026-11-17T16:08:51.396Z
canonical: https://theinference.org/article/butterfly-network-s-chip-licensing-drove-71-u-s-growth-ceo-says-it-will-dwarf-the-probe-business
language: en
keywords: "Butterfly Network, Chips, Midjourney, Earnings, Insider Trading"
---

# Butterfly Network's chip licensing drove 71% U.S. growth; CEO says it will dwarf the probe business

> The chip story is already revenue: third-quarter US growth of 71 percent came primarily from Embedded, Butterfly's chip-licensing line, including the Midjourney co-development. That counterparty has no outside investors and three studios suing it, and insider sale filings landed the same fortnight.

[Butterfly Network](https://theinference.org/markets/companies/butterfly-network)'s chief executive, Joe DeVivo, told UBS's medtech team this month that revenue from licensing the company's ultrasound semiconductor should "begin to dwarf" the handheld-probe business within a couple of years, citing more than 12 licensing partners and a fourth-generation chip due next quarter [1]. The filings from the same fortnight support the direction and set the limit: the chip money is real, and its most visible consumer endpoint belongs to [Midjourney](https://theinference.org/markets/companies/midjourney), the AI image-generation company, which has no outside investors and three studios suing it [2][3].

## The chip money is real; the fourth-quarter guide holds it flat

Revenue stepped up to $32.6 million in the second quarter and held there in the third [9]. Butterfly attributes the 71 percent jump in US revenue primarily to Embedded, its business licensing the Ultrasound-on-Chip to other companies, including the co-development with Midjourney [2]. Gross margin, at 73 percent, was the highest in the company's history [2]. The quarter still lost $12.8 million [2]. Cash stands at $122.3 million [2].

*Chart: **Operating cash has run negative in seven of eight quarters, and cash is down to $122 million** Column chart of Butterfly Network's quarterly operating cash flow against cash at quarter end, Q4 2024 through Q3 2026: operating cash flow is below zero in seven of the eight quarters and cash has fallen from $155 million to $122 million since the 2025 raise.*

*Operating cash flow and cash at quarter end, in millions of US dollars, from Butterfly Network's SEC filings. Q4 2025 was the only quarter in the span with positive operating cash flow. [10]*

Butterfly's own fourth-quarter guide, $31 million to $34 million, holds revenue on that plateau, and the last step of this size, in late 2025, fell back the following quarter [2][9]. We showed how milestone money shaped this quarter [when it landed on October 29](https://theinference.org/article/butterfly-network-s-record-quarter-ran-on-milestone-money-and-its-own-q4-guide-says-so); what is new since is the quote itself, from UBS's November 10, 2026, healthcare conference, and the filings that followed it [1][5].

A partner payment lifts one quarter; only shipped product brings the next one.

*Chart: **Butterfly's revenue stepped up to a plateau, and its own Q4 guide holds it flat** Column chart of Butterfly Network quarterly revenue from Q4 2024 through Q3 2026 with fourth-quarter 2026 guidance at midpoint, showing a step up to a plateau near $32.6 million and a guide that holds it flat.*

*Quarterly total revenue in millions of US dollars, from SEC filings. The final bar is Butterfly's Q4 2026 guidance, drawn at its $31–34 million midpoint. [2][9]*

## The consumer end of the chip story is a defendant

The Embedded product a consumer can touch is Midjourney's full-body scanner, built around 40 Butterfly ultrasound chips [4]. At launch it will map body composition only, a choice that avoids the approvals diagnostic imaging requires, with availability planned by the end of 2027 [4]. It begins with about ten scanners in a San Francisco spa [4]. None of that has changed [since we reported the scanner's specs on October 5](https://theinference.org/article/butterfly-s-74-million-midjourney-license-rests-on-a-scanner-with-no-fda-clearance-and-no-ai); what has moved is the courtroom [3]. Midjourney has no outside investors; its founder, [David Holz](https://theinference.org/markets/people/david-holz), has said subscribers pay the service's costs plus a margin [3].

Those subscribers' outputs are what Disney, Universal and Warner Bros. are suing over. The studios allege $300 million of revenue last year, no court has ruled on the fair-use defense, and a hearing on Midjourney's bid to throw out the claim that it helped users infringe is set for November 23, 2026 [3]. Damages or an injunction would land on the same subscription revenue that funds the scanner, so the chain from Butterfly's chip to a consumer now crosses a courtroom.

## The insider sales were scheduled in August, not timed to the talk

Director Jonathan Rothberg [filed notice on November 13, 2026](https://www.stocktitan.net/sec-filings/BFLY/144-butterfly-network-inc-sec-filing-888c35a109fe.html), to sell $2.23 million of stock [5]. Chief financial officer John Doherty [sold $350,000 of shares two days earlier](https://www.sec.gov/Archives/edgar/data/1804176/000206483226000337/0002064832-26-000337-index.htm) [6]. Investing.com reported DeVivo's own sale at about $635,000 [7]. The filings on record ran under trading plans adopted in mid-August, weeks before the UBS talk, so they read as scheduled diversification rather than doubt [5][6]. Three days after Rothberg's notice, Hood River Capital, an investment manager holding 4.97 percent of Butterfly's shares, [filed a routine passive-ownership update](https://www.sec.gov/Archives/edgar/data/1804176/000121465926014213/0001214659-26-014213-index.htm) [8].

## Adoption, not the chip, is what DeVivo says limits Butterfly

DeVivo's own account puts the limit in the training of the person holding the probe: he named ultrasound's learning curve as the obstacle to wider adoption [1]. About 33 companies are building AI tools inside Butterfly's ecosystem that help less-experienced users position probes and acquire images, the step that turns the chip into a clinician's tool [1]. Butterfly's community-care program does the same work on the clinical side, training nurses and collecting payment per patient and per scan, with first revenue due this month [1][2].

![An instructor guides a colleague through scanning a patient in a hospital bed with a Butterfly probe and smartphone](https://storage.googleapis.com/theinference-public/img/4989f6bb879d8140.webp)

*Butterfly trains clinicians to use the probe; its chief executive names ultrasound's learning curve, not the chip, as the limit on wider adoption. (Courtesy of Butterfly Network)*

One Embedded partner product is on the market, unnamed in the release [2]. Until partners beyond Midjourney ship from balance sheets that can pay, the dwarf claim rests on that product, one scanner, one spa and one defendant.

Price the stock on chips shipped by partners that can pay, and treat the UBS quote as a promise until then.

## Takeaway

Butterfly's chip licensing now carries its growth: 71 percent US revenue growth, a record 73 percent gross margin. But the top line has plateaued, the company's own guide holds it there, the most visible consumer partner is fighting three studios, and the insider sales were scheduled in August.

## Sources

1. [Transcript Daily, "Butterfly Network CEO Sees Chip Revenue Dwarfing Ultrasound Device Business", 17 November 2026](https://transcriptdaily.com/2026/11/17/butterfly-network-ceo-sees-chip-revenue-dwarfing-ultrasound-device-business.html)
2. [Medical Buyer, "Butterfly Network net loss hits USD 12.8M in Q3 2026" (Q3 2026 results release), 6 November 2026](https://medicalbuyer.co.in/butterfly-network-net-loss-hits-usd-12-8m-in-q3-2026/)
3. [AI News Today, "Midjourney's self-funding and the Hollywood copyright suits", 16 November 2026](https://ainews.today/articles/midjourney-self-funding-studio-lawsuits)
4. [külliyehaberajansı, "Midjourney, MRI'a Alternatif Olmayı Hedefleyen Tarayıcısını Duyurdu" (Midjourney Scanner details), 16 November 2026](https://kulliyehaberajansi.com/haber/9339-midjourney-mri-a-alternatif-olmay-hedefleyen-taray-c-s-n-duyurdu)
5. [StockTitan, "Butterfly Network director proposes $2.23M share sale" (Form 144, Jonathan Rothberg), 13 November 2026](https://www.stocktitan.net/sec-filings/BFLY/144-butterfly-network-inc-sec-filing-888c35a109fe.html)
6. [SEC EDGAR, Form 4, John N. Doherty (EVP, CFO, Butterfly Network), filed 13 November 2026](https://www.sec.gov/Archives/edgar/data/1804176/000206483226000337/0002064832-26-000337-index.htm)
7. [Investing.com (German edition), "Butterfly Network: CEO Joseph DeVivo trennt sich von Aktienpaket im Wert von rund 635.000 US-Dollar", 4 November 2026](https://de.investing.com/news/insider-trading-news/butterfly-network-ceo-joseph-devivo-trennt-sich-von-aktienpaket-im-wert-von-rund-635000-usdollar-93CH-3744993)
8. [SEC EDGAR, Schedule 13G/A, Hood River Capital Management LLC (4.97% of Butterfly Network), filed 16 November 2026](https://www.sec.gov/Archives/edgar/data/1804176/000121465926014213/0001214659-26-014213-index.htm)
9. [Butterfly Network, quarterly revenue, net income and cash from its SEC filings, retrieved 17 November 2026](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001804176)
10. [Butterfly Network, quarterly figures from its SEC filings, retrieved 17 November 2026](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001804176)


---

Butterfly Network's chip licensing drove 71% U.S. growth; CEO says it will dwarf the probe business — The Inference. Canonical: https://theinference.org/article/butterfly-network-s-chip-licensing-drove-71-u-s-growth-ceo-says-it-will-dwarf-the-probe-business
